Results 171 to 180 of about 16,022 (277)
[[alternative]]Statistical Analysis on Environmental Risk Assessment Using Pharmacokinetic Physiologically-based Model [PDF]
計畫編號：NSC91-2118-M032-001研究期間：200208~200307研究經費：434,000[[sponsorship ...
陳主智
core
Clinical and Translational Science, Volume 19, Issue 1, January 2026.ABSTRACT While the subcutaneous (SC) route of administration (RoA) is more patient‐centric and cost‐effective than the intravenous (IV) RoA, the Switch‐to‐SC paradigm has been employed in oncology antibody drug development. T cell engagers (TCEs) are typically highly potent and efficacious at low doses, supporting their suitability for the Direct‐to‐SC
Wenlian Qiao +3 more
wiley +1 more source
Modeling and Simulation of Triclosan Kinetics and Distribution in Humans Using a PBPK Model [PDF]
, 2015 Andreassen, Monica +5 more
core +4 more sources
A translational platform PBPK model for antibody disposition in the brain
, 2019 Hsueh-Yuan Chang +3 more
openalex +2 more sources
This deliverable will report the final development of the human PBPK models developed within ...
openaire +1 more source
295P Physiologically based pharmacokinetic (PBPK) modeling of the central nervous system (CNS) pharmacokinetics of tucatinib in patients with breast cancer brain metastasis [PDF]
, 2020 Anthony Lee +5 more
openalex +1 more source
A PBPK model of Low-concentration Vitamin D Supplementation in the Absence of Sunlight [PDF]
, 2019 Sawyer, Colton
core +1 more source